Navigation Links
Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
Date:3/20/2008

VANCOUVER, March 20 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the Credit Suisse Global Leveraged Finance Conference, which is being held March 24-27 in Phoenix, Arizona.

Mr. Thomas Bailey, Angiotech's Chief Financial Officer, is scheduled to present on Wednesday, March 26, beginning at approximately 8:00 am Mountain Time. A question and answer session will immediately follow the presentation.

Presentations at this conference will not be webcast. More information is available on the Angiotech website (http://www.angiotech.com) under the Investors section.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.

CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
2. Angiotech to participate in Lehman Brothers Healthcare Conference
3. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
4. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
5. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
6. Angiotech announces results for the fourth quarter ended December 31, 2007
7. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
9. Angiotech and Symphony Medical Announce Licensing Agreement
10. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)... to support the achievement of several,value-creat...asti Pharma, LAVAL, QC, Oct. 9 /PRNewswire-FirstC...ies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT ...essfully completed as of,October 8, 2008, the priv...or gross proceeds of $2,750,000., The convertible...
(Date:10/9/2008)... Commercial Bank Loan With Interest Payment Subsid... Biotech Ltd. (Amex:,SVA), a vaccine-focused biote...ing Zhongguancun Enterprises Credit Promotion Asso... Park organized an annual Business,Credit Rating p...o. Ltd.,s,("the Company") credit rating was succes...
(Date:10/9/2008).... 9 /- Alfacell Corporation...lished in Cell Cycle (2008;,Vol. 7, Issue 20) repo...fering RNA (siRNA), likely within the RNA-induced ...RNAi) mechanism., The paper is the result of rese...cer Research Institute and Department of Pathology...
(Date:10/8/2008)...und the world join forces in the Global Fight Agai...malaria has focused on the parasite Plasmodium fal...t form of the disease, there are other parasites o... form of malaria, are gaining notoriety. This is t...ted almost 300 million cases of malaria each year,...
Breaking Biology Technology:Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 3Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 4Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating 2Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating 3Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA 2Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA 3The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria 2The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria 3
...palities around the Midwest looking for new ways t...raditional approaches of bringing in developers to...thers are trying to entice businesses with tax inc...thin their municipalities. , ,This is a common pr...iving away tax incentives and adjusting building c...
...06, the Supreme Court in eBay Inc. v. Mercexchange...infringement should be granted an injunction must ... Those factors are (1) irreparable injury; (2) ina...hips; and (4) the public interest. The Court rejec...ion should be granted where infringement is found ...
...ifornia taxpayer and consumer rights group believe...ens the position of the Wisconsin Alumni Research... spokesman for the Wisconsin foundation said its r...uticals case demonstrates its ability to defend pa...axpayer and Consumer Rights , based in Santa Monic...
...Jim Doyle has signed into law Senate Bill 338, whi...ic obstacles that stand in the way of University o...ld help researchers more quickly turn research ide...current law requires a lengthy, bureaucratic revie...esses based on their research, and the delay resul...
Other Biology Technology:Electronic signs for municipalities: Las Vegas or lost revenues? 2Electronic signs for municipalities: Las Vegas or lost revenues? 3Electronic signs for municipalities: Las Vegas or lost revenues? 4Supreme Court decision in eBay case could affect value of patents 2California group says ruling weakens WARF's stem cell patent 2California group says ruling weakens WARF's stem cell patent 3California group says ruling weakens WARF's stem cell patent 4
(Date:10/10/2008)...go a little gooey, but it,s not turning mums, brai...rs at The Australian National University. , The ...esearch (CMHR) at ANU suggests that despite fears...nitive functions, there is no evidence to suggest ...art of Mental Health Week, which runs until tomorr...
(Date:10/9/2008)...tCall/ -- Aware, Inc. (Nasdaq:,AWRE), a leading su...ware,has scheduled a conference call to discuss t...er of 2008 on Thursday, October 23, 2008, at 5:00 ...k Moberg will host the,earnings conference call., ...accessed on the,Investor Relations page of our web...
(Date:10/9/2008)...ar Biology Laboratory (EMBL) have generated a digi...ental blueprint of a vertebrate. With a newly deve...me track all cells for the first 24 hours in the l...o a three-dimensional, digital representation of t...ine issue of Science , grants many new insights i...
(Date:10/9/2008)...donesian government and World Wildlife Fund (WWF) ...emaining forests and critical ecosystems of Sumatr...ld,s most diverse and endangered forests. The hi...wide commitment to protect Sumatra,s stunning biod...governors of all provinces across Sumatra, the wor...
Breaking Biology News(10 mins):Pregnancy not turning minds to mush: Study 2Aware Announces Q3 2008 Earnings Conference Call 2Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate 2Saving Sumatra: Indonesia reaches historic agreement 23 Columbia University Medical Center faculty elected to Institute of Medicine 733 13 Columbia University Medical Center faculty elected to Institute of Medicine 733 2Speedy Mini Stroke Care Pays Off 3240 1Speedy Mini Stroke Care Pays Off 3240 2MADD AMA NTSB IIHS and Others Launch Support 21 Coalition 3238 1MADD AMA NTSB IIHS and Others Launch Support 21 Coalition 3238 2MADD AMA NTSB IIHS and Others Launch Support 21 Coalition 3238 3MADD AMA NTSB IIHS and Others Launch Support 21 Coalition 3238 4HR Under the Microscope 3A Metrics to Drive Costs Down Across HR Functions 3236 1HR Under the Microscope 3A Metrics to Drive Costs Down Across HR Functions 3236 2
...emical Senses Center have found that taking as lit...dor results in more accurate identification of tha...rtant implications regarding how olfactory informa...r in the August issue of Neuron. , By demonstrat...e and accurate odor identification, the Monell res...
...hat a novel environment sparks exploration and lea...brain really prefers novelty as such. Rather, the ...bstantia nigra/ventral tegmental area (SN/VTA)--mi...us, the emotional arousal it causes, or the need t...influence on learning because it is functionally l...
... with the ring-shaped stains that result from spil...n is not evenly distributed, but instead concentra... professor of materials science and engineering, p...linois at Urbana-Champaign has found the same "cof...ain insights into the physics behind the ring phen...
...that our heart beats, we need proteins with specia...h give our tissues the necessary strength and take... are also interesting as building blocks for novel... often outperform the artificial: One only has to ...proof spider dragline silk. Molecules with defined...
Other Biology News:Quick -- what’s that smell? 2Pure novelty spurs the brain 2Ring-like formations in drying DNA drops could affect hybridization studies 2Proteins as parents 2
...complete and professional software for microarray ...ts makes it is possible to work with different lay...d Cy5, standard deviations, error values, etc., as... Also unique is the full error handling through al...
Cartesian Array Human Cytokine Set 1 from BioSource International (Invitrogen)
Rabbit Anti-Rat Heme Oxygenase-1 (2-23) Polyclonal Antibody, Unconjugated from Calbiochem
...s the most highly integrated comprehensive environ...ecular biology data management available on Mac OS...manage view analyze transform share and publicize ... one integrated analysis environment., ,Catal...
Biology Products: